Clinical Trials Logo

Filter by:
NCT ID: NCT00613574 Completed - COPD Clinical Trials

RUSSE / Russian Spiriva® Safety & Efficacy Study

Start date: n/a
Phase: Phase 4
Study type: Observational

At the moment, there is hardly any structured safety and efficacy data collection on Tiotropium in Russia. Therefore, the objective of this observational study is to collect and evaluate data on bronchodilator efficacy and safety of Spiriva® (18 µg tiotropium inhalation capsules) delivered by HandiHaler®, in a national sample of Russian patients with varying severities of chronic obstructive pulmonary disease (COPD) in a real life setting over the 8 weeks.

NCT ID: NCT00620581 Completed - Clinical trials for Premenstrual Dysphoric Disorder

Luteal Phase Administration of Paroxetine for the Treatment of PMDD

PMDD
Start date: n/a
Phase: Phase 3
Study type: Interventional

The efficacy of SSRI use to relieve the symptoms associated with premenstrual dysphoric disorder has been established. We proposed to test the hypothesis that intermittent treatment with paroxetine administered during the luteal phase of the menstrual cycle only is more effective than placebo in improving symptoms of PMDD. This was a double-blind, placebo-controlled, three-arm parallel group study of patients with PMDD. Menstruating women 18 years of age or older who met criteria for inclusion in the study were randomized to one of three arms: paroxetine 10mg/day during the luteal phase of the menstrual cycle; paroxetine 20mg/day during the luteal phase of the menstrual cycle; placebo daily during the luteal phase of the menstrual cycle. The objective was to evaluate the efficacy and safety of intermittent treatment of paroxetine in women with PMDD.

NCT ID: NCT00622791 Completed - Clinical trials for Coronary Artery Disease

Propofol Pharmacokinetics and Pharmacodynamics During Cardiopulmonary Bypass

Start date: n/a
Phase: N/A
Study type: Observational

Cardiopulmonary bypass (CPB) is known to alter pharmacokinetics (PK) and brain sensitivity to several drugs, including propofol. Few studies, however, have tested if propofol pharmacokinetical alterations observed after CPB could contribute to the increased hypnotic effect of propofol after CPB. This study was designed to test the hypothesis that changes in the PK of propofol contribute to an increase in its hypnotic effects after CPB as evidenced by changes in bispectral index (BIS) values. Twenty undergoing coronary artery bypass graft patients will be allocated in two groups: 1) CPB groups and 2) off-pump coronary artery bypass graft. Bispectral Index values and blood samples for plasma propofol concentration measurements will be collected along the surgery and up to 12 hours in the post-operative period. Plasma propofol concentrations, Bispectral index values and propofol PK will be compared between the groups.

NCT ID: NCT00625157 Completed - Clinical trials for Discoid Lupus Erythematosus

Efficacy and Safety of ASF-1096 Cream 0.5% in the Treatment of Discoid Lupus Erythematosus (DLE) Lesions (2)

Start date: n/a
Phase: Phase 2
Study type: Interventional

Lupus Erythematosus (LE) is an autoimmune disorder that includes a broad spectrum of clinical forms. One of these forms, Discoid Lupus Erythematosus (DLE) is a chronic disfiguring disease confined to the skin. The aim of this pivotal trial is to investigate the efficacy and safety of ASF-1096 cream 0.5% in the treatment of patients with DLE or SLE presenting newly developed discoid lesions.

NCT ID: NCT00629213 Completed - Metabolic Syndrome Clinical Trials

Metabolic Syndrome Risk Factor in IGT: STOP-NIDDM Trial

Start date: n/a
Phase: Phase 3
Study type: Interventional

The aim of the study was to analyse the independent and joint effects of the components of the metabolic syndrome (MetS) on the incidence of diabetes in people with impaired glucose tolerance (IGT) and to assess the effect of acarbose by MetS status. Double-blind placebo controlled trial, 1,368 patients, follow-up time 3.3 years. MetS by ATP III definition with fasting plasma glucose of ≥ 6.1 mmol/l as limit for impaired fasting glucose (IFG).

NCT ID: NCT00629785 Completed - Obesity Clinical Trials

The Analysis of BMI, Asthma Prevalence, and Lung Functions of Schoolchildren in Southern Taiwan

Start date: n/a
Phase: N/A
Study type: Observational

The prevalence of obesity and asthma has increased in recent decades. We investigated the relationship between body mass index (BMI) and lung function, and also tried to determine if asthma prevalence differs between obese and non-obese children. We propose this cross-sectional, retrospective analysis to figure out whether the BMI is associated with elevated prevalence of asthma, and how their lung function changes in different BMI groups.

NCT ID: NCT00630604 Completed - Osteoarthritis Clinical Trials

Quantitative Ultrasonography (US) Evaluation on Femoral Condyle Cartilage

US
Start date: n/a
Phase: N/A
Study type: Observational

The purpose of this study is to investigate the feasibility of using quantitative ultrasonography (US) evaluation to determine the severity of osteoarthritic femoral condyle cartilage erosion.

NCT ID: NCT00643422 Completed - Healthy Clinical Trials

Reproducibility of Cirrus Optical Coherence Tomography Measurements

Start date: n/a
Phase: N/A
Study type: Observational

In this study the reproducibility of optical coherence tomography measurements should be evaluated.

NCT ID: NCT00643552 Completed - Down Syndrome Clinical Trials

Muscle Strength, Physical Work Capacity and Functional Performance in Individuals With Down Syndrome

Start date: n/a
Phase: N/A
Study type: Observational

This project will evaluate muscle strength and its relationship to everyday function in individuals with Down Syndrome.

NCT ID: NCT00645554 Completed - Pharmacokinetics Clinical Trials

A Single Dose, Cross-over Bioequivence Study Comparing Galantamine IR (Immediate Release) Table and Galantmine OS (Oral Solution) in Healthy Volunteers

Start date: n/a
Phase: Phase 1
Study type: Interventional

The purpose of this open-label, single dose, two-treatment, two-period, cross-over study is to evaluate the pharmacokinetic profile and tolerability of galantamine oral solution and galantamine tablet.